Close

Professor James Logan

Bsc PhD FRES

Professor
Professor and CEO of Arctech Innovation Ltd

Room
408 & LG38

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

James is a Professor at the London School of Hygiene & Tropical Medicine (LSHTM), and was Head of the Department of Disease Control for 4 years. He is also Co-Founder and CEO of Arctech Innovation, a world-leading innovation centre for breakthrough research, evaluation and commercialisation of new, game-changing products for the surveillance and control of diseases. 

He is the Principal Investigator of a large research portfolio, investigating novel diagnostics, surveillance and control technologies for diseases including COVID-19, malaria, Zika, dengue, trachoma and Lyme disease. James is the UK's leading expert on insect repellents and methods of personal protection against arthropod vectors. His work also aims to identify and understand chemical signals given off by the human body during infection and use these as biomarkers of diseases for the development of non-invasive diagnostics.

Arctech Innovation is a spin-out company from LSHTM, established after the acquisition of ARCTEC, A Centre of Excellence for Entomology and Vector Control, by Vecotech.Both companies were co-founded and led by James. Arctech Innovation has established a Good Laboratory Practice (GLP)-compliant laboratory with excellent facilities and clinical trials team for independent testing and evaluation of products on behalf of commercial clients. James is an inventor on patents in Arctech Innovation’s portfolio of disruptive products for diagnostics of disease, and the control of pests and vectors.

James began his career with a first class BSc honours degree in Zoology from the University of Aberdeen in 2001 and an award-winning PhD in 2005. He then led a research group at Rothamsted Research, as Senior Postdoctoral Research Scientist, within the Chemical Ecology Programme, before joining the School.

James is a Fellow of the Royal Entomological Society, Chair of the Public Engagement Committee and a member of the Innovations Committee.

James is an avid science communicator and is Science Ambassador for the Science Technology Engineering and Mathematics Network (STEMNET) which aims to inspire young people in science. James is also a science TV presenter, currently working on exciting programmes with the BBC and Channel 4. He also makes regular appearances on television, radio and in print media as a scientific expert.

James enjoys taking part in charity work and is a Patron of Medical Aid Films, which uses innovative media to transform the health and wellbeing of women and children around the world.

 

Affiliations

Faculty of Infectious and Tropical Diseases
Department of Disease Control

Centres

Malaria Centre

Teaching

James is Lead Educator for the free online course on Zika and another on Vector Control (MOOC). He is also Module Organiser of the Integrated Vector Management Module and the residential field trip for entomology and parasitology for the MSc course, Biology and Control of Disease Vectors. He teaches on several other MSc courses including Medical Parasitology, Control of Infectious Diseases, Tropical Medicine and International Health, Diploma in Tropical Medicine & Hygiene and the Short Course on Travel Medicine. James also supervises several PhD projects and MSc summer projects. 

Research

Logan Research Group


The Logan research group investigates novel ways to control arthropod vectors that transmit pathogens of human and animal diseases in the UK and overseas by exploring:

  • the interaction between arthropods, animal/human hosts and pathogens at the olfactory and behavioural level 
  • aspects of insect ecology including aggregation, mating and oviposition in a variety of arthropods
  • the mode of action of new (and current) monitoring and control techniques
  • the development of new or improved control technologies
The Logan group also works on the idientification of disease biomarkers in human odour, using insects as biosensors. 


The Logan laboratories are equipped with state-of-the-art experimental facilities including electroantennography, single sensillum recording, gas chromatography, RT-PCR and behavioural olfactometry, as well as Category 3 facilities which allow complex malaria infection studies with Anopheles gambiae mosquitoes and Plasmodium falciparum parasites.

 

 

Arctech Innovation

Arctech Innovation is a spin-out company from LSHTM with a mission to save lives by creating and delivering public health innovation and global social impact. It comprises three core divisions:

  • Innovation: translating academic scientific discoveries and novel IP into commercial products using its proprietary Semeion IQ™ chemical ecology platform.
  • Contract research: offering clinical trial and product evaluation services to commercial clients, from experimental testing to large-scale field and clinical trials, to enable product development and product registration.
  • Social impact: delivering educational, training and behaviour change projects which have a positive impact on the health and wellbeing of individuals and communities around the world.

Arctech Innovation has an outstanding global reputation for running clinical trials, as well as independent efficacy testing and evaluation of arthropod control products including repellents, insecticides, lures, traps and head lice treatments within its GLP compliant laboratories.

To enquire about its independent efficacy testing services, or to explore collaborative opportunities in social impact or product innovation, visit www.arctechinnovation.com

Research Area
Clinical trials
Diagnostics
Hygiene
Insects
Parasites
Public health
Viruses
Disease control
Public understanding
Vector control
Discipline
Biochemistry
Molecular biology
Parasitology
Vector biology
Entomology
Disease and Health Conditions
Bluetongue virus
Malaria
Pandemic diseases
Trachoma
Emerging Infectious Disease
Neglected Tropical Diseases (NTDs)
Respiratory disease
Tropical diseases
Vector borne disease
Zoonotic disease
Dengue
Coronavirus
Zika
Country
Brazil
Colombia
Germany
France
United Kingdom
The Gambia
India
Thailand
United States of America
Region
East Asia & Pacific (all income levels)
Europe & Central Asia (all income levels)
European Union
Latin America & Caribbean (all income levels)
Middle East & North Africa (all income levels)
OECD members
Sub-Saharan Africa (all income levels)

Selected Publications

Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study.
Guest C; Dewhirst SY; Lindsay SW; Allen DJ; Aziz S; Baerenbold O; Bradley J; Chabildas U; Chen-Hussey V; Clifford S
2022
Journal of travel medicine
Travel measures in the SARS-CoV-2 variant era need clear objectives.
Kucharski AJ; Jit M; Logan JG; Cotten M; Clifford S; Quilty BJ; Russell TW; Peeling RW; Antonio M; Heymann DL
2022
Lancet (London, England)
Skin microbiome alters attractiveness to Anopheles mosquitoes.
Showering A; Martinez J; Benavente ED; Gezan SA; Jones RT; Oke C; Tytheridge S; Pretorius E; Scott D; Allen RL
2022
BMC microbiology
The legacy of ZikaPLAN: a transnational research consortium addressing Zika.
Wilder-Smith A; Brickley EB; Ximenes RADA; Miranda-Filho DDB; Turchi Martelli CM; Solomon T; Jacobs BC; Pardo CA; Osorio L; Parra B
2022
Global health action
Public health messages on arboviruses transmitted by Aedes aegypti in Brazil.
Clancy IL; Jones RT; Power GM; Logan JG; Iriart JAB; Massad E; Kinsman J
2021
BMC public health
Towards an odour-baited trap to control Musca sorbens, the putative vector of trachoma.
Robinson A; Bickford-Smith J; Abdurahman Shafi O; Abraham Aga M; Shuka G; Debela D; Hordofa G; Alemayehu W; Sarah V; Last A
2021
Scientific reports
Primary and secondary measurements collected when trialling use of insecticide-treated scarves to protect against Musca sorbens
Robinson A; Reis de Oliveira Gomes L; Abdurahman OS; Alemayehu W; Shuka G; Melese E; Guye M; Legesse D; Elias E; Temam K
2021
See more Publications